Article Details

US FDA Approves IBRANCE® (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic ...

Retrieved on: 2019-04-04 02:56:15

Tags for this article:

Click the tags to see associated articles and topics

US FDA Approves IBRANCE® (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic .... View article details on hiswai:

Excerpt

<div>... patients sourced from three databases: IQVIA Insurance database, <b>Flatiron</b> <b>Health</b> Breast Cancer database and the Pfizer global safety database.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo